1114-34-7
1114-34-7
Chemical Structure
D-Lyxose
- CAS No.: 1114-34-7
- Formula:C5H10O5
- Molecular Weight:150.13
IUPAC Name: (2S,3S,4R)-2,3,4,5-tetrahydroxypentanal
InChIKey: PYMYPHUHKUWMLA-UOWFLXDJSA-N
SMILES: O=C[C@H]([C@H]([C@@H](CO)O)O)O
Biological Activity: D-Lyxose is an endogenous metabolite. D-Lyxose is a rare pentose with significant potential for pharmaceutical synthesis. D-Lyxose serves as a starting material for antitumor agents (such as α-galactosylceramide-based immunostimulants). D-Lyxose acts as a precursor for L-nucleoside analogs used in the development of antiviral drugs. D-Lyxose can be used as a synthetic intermediate for other rare sugars (such as L-ribose)[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
D-Lyxose | 98.0% | D-Lyxose is an endogenous metabolite. D-Lyxose is a rare pentose with significant potential for pharmaceutical synthesis. D-Lyxose serves as a starting material for antitumor agents (such as α-galactosylceramide-based immunostimulants). D-Lyxose acts as a precursor for L-nucleoside analogs used in the development of antiviral drugs. D-Lyxose can be used as a synthetic intermediate for other rare sugars (such as L-ribose). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
D-Lyxose (Standard) | ≥98% | D-Lyxose (Standard) is the analytical standard of D-Lyxose. This product is intended for research and analytical applications. D-Lyxose is an endogenous metabolite. D-Lyxose is a rare pentose sugar with significant potential for drug synthesis. D-Lyxose can be used as a starting material for anti-tumor drugs such as alpha galactose ceramide immunostimulants. D-Lyxose can be used as a precursor for L-nucleoside analogs for the development of antiviral drugs. D-Lyxose can be used as a synthetic intermediate for other rare sugars such as L-ribose. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
D-Lyxose-13C-2 | D-Lyxose-13C-2 is the 13C labeled D-Lyxose. D-Lyxose is an endogenous metabolite. D-Lyxose is a rare pentose sugar with significant potential for drug synthesis. D-Lyxose can be used as a starting material for anti-tumor drugs such as alpha galactose ceramide immunostimulants. D-Lyxose can be used as a precursor for L-nucleoside analogs for the development of antiviral drugs. D-Lyxose can be used as a synthetic intermediate for other rare sugars such as L-ribose. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
D-Lyxose-d | D-Lyxose-d is the deuterium labeled D-Lyxose. D-Lyxose is an endogenous metabolite. D-Lyxose is a rare pentose sugar with significant potential for drug synthesis. D-Lyxose can be used as a starting material for anti-tumor drugs such as alpha galactose ceramide immunostimulants. D-Lyxose can be used as a precursor for L-nucleoside analogs for the development of antiviral drugs. D-Lyxose can be used as a synthetic intermediate for other rare sugars such as L-ribose. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
D-Lyxose-d-1 | D-Lyxose-d-1 is the deuterium labeled D-Lyxose. D-Lyxose is an endogenous metabolite. D-Lyxose is a rare pentose sugar with significant potential for drug synthesis. D-Lyxose can be used as a starting material for anti-tumor drugs such as alpha galactose ceramide immunostimulants. D-Lyxose can be used as a precursor for L-nucleoside analogs for the development of antiviral drugs. D-Lyxose can be used as a synthetic intermediate for other rare sugars such as L-ribose. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
D-Lyxose-13C-4 | D-Lyxose-13C-4 is the 13C labeled D-Lyxose. D-Lyxose is an endogenous metabolite. D-Lyxose is a rare pentose sugar with significant potential for drug synthesis. D-Lyxose can be used as a starting material for anti-tumor drugs such as alpha galactose ceramide immunostimulants. D-Lyxose can be used as a precursor for L-nucleoside analogs for the development of antiviral drugs. D-Lyxose can be used as a synthetic intermediate for other rare sugars such as L-ribose. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
D-Lyxose-13C-3 | D-Lyxose-13C-3 is the 13C labeled D-Lyxose. D-Lyxose is an endogenous metabolite. D-Lyxose is a rare pentose sugar with significant potential for drug synthesis. D-Lyxose can be used as a starting material for anti-tumor drugs such as alpha galactose ceramide immunostimulants. D-Lyxose can be used as a precursor for L-nucleoside analogs for the development of antiviral drugs. D-Lyxose can be used as a synthetic intermediate for other rare sugars such as L-ribose. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Structural Analogs
-
Similarity Score 1.00
HY-78139SL-Xylose-1-13C -
Similarity Score 1.00
HY-N0059D-Arabinose -
Similarity Score 1.00
HY-N0059S1D-Arabinose-13C-1 -
Similarity Score 1.00
HY-N0059S3D-Arabinose-13C-3 -
Similarity Score 1.00
HY-N0537S3Xylose-2-13C -
Similarity Score 1.00
HY-N0537S4Xylose-5-13C -
Similarity Score 1.00
HY-N2353RArabinose (Standard) -
Similarity Score 1.00
HY-W018772S4D-Ribose-13C-3 -
Similarity Score 1.00
HY-W779019Xylose-13C5 -
Explore the MedChemAI to find more analogs
References
- [1]. Kwon HJ, et al. Substrate specificity of a recombinant D-lyxose isomerase from Providencia stuartii for monosaccharides. J Biosci Bioeng. 2010;110(1):26-31. [Content Brief]
- [2]. Cho EA, et al. Characterization of a novel D-lyxose isomerase from Cohnella laevoribosii RI-39 sp. nov. J Bacteriol. 2007;189(5):1655-1663. [Content Brief]
